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The relative effectiveness of bolus vs. constant intravenous administration of equivalent
doses of penicillin G in killing bacteria in vivo was studied in a rabbit model of meningi-
tis due to Streptococcus pneumoniae. Samples of cerebrospinal fluid (CSF) and serum
were obtained from 30 rabbits at intervals of ~8 hr after treatment for determination of
antibiotic concentrations and titers of viable bacteria in the CSF. When penicillin G was
given by continuous infusion (105 units/hr after an initial lOS-unit loading dose), con-
centrations of drug in serum and CSF reached a steady state in 1 hr. With intermittent
bolus administration of 4 x 105 units every 4 hr, higher peak and lower trough concen-
trations were achieved, and these concentrations paralleled those in the CSF. Although
an initial acceleration in bactericidal rate was observed with the bolus infusion between
the first and second hour of therapy, after the second hour the rate of bacterial killing
was identical for the two methods of administration. The duration of therapy required
for sterilization of the CSF was dependent only on the bacterial count before treatment
and not on the mode of drug administration. The effect of single bolus intravenous ad-
ministration of ampicillin was examined in experimental pneumococcal meningitis. Am-
picillin was given at various dosages (3.25-62.5 mg/kg), and frequent samples of CSF
were obtained for determination of concentrations of pneumococci and ampicillin. A
long postantibiotic effect was observed in the CSF of all animals, and this effect consis-
tently was longer than that observed in vitro.
The question of the most effective mode of admin-
istration of (3-lactam antibiotics for treatment of
severe bacterial infections is controversial. Com-
monly used regimens are largely empirical and are
based on pharmacokinetic parameters (often only
available from studies done with normal volun-
teers), knowledge of susceptibility characteristics
of the suspected pathogen, and tradition. Paren-
teral therapy is preferred, but unpredictable ab-
sorption (e.g., shock) and clotting abnormalities
may make the im route unreliable. Continuous iv
administration produces a relatively fixed concen-
tration of the antibiotic over time. Intermittent, or
bolus, administration produces high initial con-
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centrations in serum that are followed by a rapid
fall in levels of drug. Both intermittent and contin-
ous modes of administration have their advocates,
whose opinions usually are based on studies that
examined the effect of the mode of antibiotic ad-
ministration on survival of animals with experi-
mental infections [1-3]. Other studies have ap-
proached this problem by examining the dynamics
of penetration of antibiotics into restricted sites as
a function of the mode of drug administration [4,
5]. None of these investigations have examined the
kinetics of bacterial stasis and killing, factors that
might influence the rate of response to therapy.
Both types of regimens usually are adjusted to
achieve concentrations of drug in serum above the
MIC for the duration of therapy. However, clini-
cal experience suggests that administration of
these large doses may not be necessary. Pneumo-
coccal pneumonia can be cured with only 8 x 103
to 1.2 X 104 units of penicillin G given every 12 hr
[6], despite concentrations of drug in tissue below
the MIC. Cure of scarlet fever has occurred when
penicillin was detectable in the serum for only 6 hr
per day [7]. Eagle et al. [1, 2, 8] eradicated experi-
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mental streptococcal infections, despite antibiotic
levels in tissue below the MIC during each treat-
ment interval; they ascribed this result to a persis-
tent effect of the drug on the organism, a phenom-
enon described by Parker et al. more than 30 years
ago [9, 10]. The postantibiotic effect has been
clarified further by in vitro studies [11, 12], in
which short-term exposure of Staphylococcus
aureus or Escherichia coli to various antibiotics at
or above the MIC produced a continued postanti-
biotic effect (decreased or stable bacterial counts)
for various periods of time after removal of the
antibiotic. Even subinhibitory levels of antibiotics
can alter the growth rate and morphology of bac-
teria [13] and may modify important host defense
mechanisms [14, 15]. Previous exposure of E. coli
to sub-MIC levels of chloramphenicol resulted in a
prolonged decline in bacterial concentrations after
exposure of the culture to leukocytes, antibody,
and complement in vitro [12]. Thus, in vivo, con-
tact of the organism with subtherapeutic concen-
trations of drug may potentiate host defenses and
playa role in outcome of therapy. However, these
kinetic concepts have not as yet been demon-
strated in vivo.
We have used a rabbit model of pneumococcal
meningitis to study these problems. The purposes
of our investigations were (1) to compare the ef-
fect of continuous vs. intermittent iv administra-
tion of penicillin on the kinetics of drug concen-
tration and the rate of bacterial killing in the CSF
in vivo, and (2) to examine the sequence and dura-
tion of bactericidal and bacteriostatic effects in
vivo produced by a single bolus infusion of ampi-
cillin.
Materials and Methods
Streptococcus pneumoniae. A strain of S.
pneumoniae type 3 originally isolated from the
blood and CSF of an adult with meningitis and
previously characterized in our laboratory [16]
was used. The strain was grown (from the same
stock culture on glass beads) in trypticase soy
broth (TSB; Difco Laboratories, Detroit, Mich.)
supplemented with 5070 defibrinated sheep blood
for 18 hr at 37 C in an atmosphere of 10070
COr 90OJo air. Before inoculation the culture was
centrifuged at 200 g. for 5 min for removal of
erythrocytes, centrifuged again at 2,000 g for 15
min, washed twice in 0.9070 NaCI, and suspended
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in 2.0 ml of 0.9070 NaCI. This procedure provided
an inoculum of 107 cfu, which was verified for
each experiment by quantitative plating on tryp-
ticase soy agar (TSA) pour plates.
In vitro studies The MICs and MBCs of peni-
cillin and ampicillin were determined by a micro-
titer method in heart infusion broth with inocula
of 104 or 106 cfu [16, 17].
In addition, the effects of in vitro exposure of
the organism to ampicillin for short periods were
examined by quantitative "time-kill" methods. S.
pneumoniae type 3 was grown for 18 hr in TSB
plus 5070 sheep blood at 37 C in 10070 CO2-90OJo
air. This culture was diluted 10-4 , transferred to
fresh media, and incubated under identical condi-
tions for 5 hr until the culture reached log phase.
A 10-1 dilution (1.0 ml) of this culture was divided
into five 25-ml cotton-stoppered flasks, each con-
taining 10 ml of fresh media. After incubation for
1 hr, quantitative titers of bacteria were measured
by 10-fold dilutions on TSA pour plates supple-
mented with sheep blood. Standardized ampicillin
powder (Wyeth Laboratories, Philadelphia, Pa.)
was dissolved in 0.9070 NaCI and added to the
flasks; the final concentrations of drug were 0.01,
0.1, 1.0, and 10 IAg/ml. One flask contained no an-
tibiotic and served as a control. After administra-
tion of ampicillin, all flasks were incubated at 37
C in 10070 COr 90OJo air with continuous shaking
for 2 hr. Antibiotic was then removed by cen-
trifugation (2,000 g for 10 min); the pelleted
bacteria were washed three times with 10 ml of
0.9070 NaCI and suspended in fresh TSB contain-
ing sheep blood. Bacterial concentrations were
counted with use of quantitative pour plates at this
time, then every hour for 3 hr, and every 2 hr for
18 hr.
Rabbit model of meningitis. Pneumococcal
meningitis was produced in New Zealand white
rabbits or Russian hares weighing 2-3 kg as de-
scribed previously [16, 17]. Anesthesia was in-
duced with 30 mg of sodium pentobartital (Barber
Veterinary Supply Co., Richmond, Va.) adminis-
tered iv, and a dental acrylic "helmet" was at-
tached to the animal's skull to facilitate immobil-
ization in a stereotaxic frame. Several days later,
the animals were anesthetized again, placed in the
stereotaxic frame, and inoculated intracisternally
with 107 cfu of S. pneumoniae via a Quincke
spinal needle (25 gauge x 3 Y2 in) held in a geared
electrode introducer. All therapeutic experiments
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were performed 16-18 hr after inoculation when
the rabbits had meningitis, as manifested by fever
(temperature, >39.6 C), lethargy, and other
neurologic signs: cerebrospinal fluid (CSF)
pleocytosis (~95 070 polymorphonuclear leukocytes
[PMNs]) and bacterial titers in CSF that ranged
from 104 to >108 cfu/ml. Only animals with con-
centrations of bacteria in CSF of >104 cfu/ml
(~95OJo of all inoculated rabbits) were included for
analysis. If untreated, this degree of meningitis is
uniformly fatal within 24-36 hr.
Experimental design: intermittent vs. continu-
ous penicillin therapy. After reinduction of light
anesthesia with sodium pentobarbital, indwelling
femoral arterial and venous catheters (Intra-
medic® polyethyene tubing 7420, Clay-Adams,
Parsippany, N.J.) were placed, and the animals
positioned in the stereotaxic frame. Two groups of
15 animals each received iv penicillin G (Bristol
Laboratories, Syracuse, N. Y.) by the intermittent
or continuous mode of administration. The inter-
mittent group received 4 x 105 units given as a
bolus over 2 min; two such doses were given, 4 hr
apart. The animals in the continuously treated
group were treated iv with an initial loading dose
of 105 units, followed by 105 units/hr given via a
syringe infusion pump (model 352; Sage Instru-
ments, White Plains, N.Y.) for the 8 hr of obser-
vation. Samples of serum and CSF were taken si-
multaneously at 0, 1, 2, 4, 5, 6, and 8 hr of ther-
apy. CSF was withdrawn in 0.3-ml aliquots, of
which 0.2 ml was used for quantitative culture and
0.1 ml for determination of the penicillin concen-
tration. Samples for culture were treated with
penicillinase (5,000 units/ml of CSF) for inactiva-
tion of the residual penicillin and either were
plated directly without dilution (0.1 ml) or were
serially diluted and quantitatively titrated on TSA
blood agar pour plates, which were incubated in
10070 COr 90OJo air at 37 C for 24 hr. Serum
samples, in 1.0-ml aliquots from the femoral ar-
tery catheter, were used for determinations of the
penicillin concentration.
Single-dose ampicillin therapy. Procedures
identical to those described above were followed
in these experiments, except that ampicillin was
used instead of penicillin and the drug was given
as a single iv bolus in one of the following dos-
ages: 3.25, 6.5, 12.5, 25, 37.5, or 62.5 mg/kg.
Samples of CSF and serum were withdrawn for
determination of quantitative bacterial counts and
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ampicillin concentrations at intervals of 0.25, 0.5,
0.75, 1, 1.5,2,2.5,3,4,6, and 8 hr after adminis-
tration of ampicillin and at frequent intervals
thereafter for up to 24 hr or until the animal died,
whichever occurred first.
Antibiotic assay. Concentrations of penicillin
and ampicillin were determined by an agar well
diffusion technique [18]. Assay plates (diameter,
105 mm) were prepared by the addition of a Bacil-
lus subtilis spore suspension (0.2 ml) to 100 ml of
antibiotic medium no. 1 (Difco). Wells of rvO.6 x
0.6 cm were cut and filled with rvO.03 ml of serum
or CSF. All samples and standards were tested in
triplicate. Serum standards consisted of known
concentrations of penicillin or ampicillin dissolved
in pooled rabbit serum. CSF standards were
prepared in 0.9070 NaCl since identical zones were
observed for standards prepared in uninfected
rabbit CSF, infected rabbit CSF, or 0.9070 NaCI.
Infected rabbit CSF did not produce a zone of in-
hibition in this assay. The smallest concentration
of drug that could be measured accurately was 0.1
jAg/mI.
Results
In vitro susceptibility. All MICs and MBCs of
penicillin were 0.06 jAg/ml for the test strain at
both inocula examined, i.e., 104 or 106 cfu/mI.
Corresponding MICs and MBCs of ampicillin
were 0.06-0.08 jAg/ml at 104 cfu/ml and 0.1-0.125
jAg/ml at 106 cfu/mI.
(1) Intermittent vs. continuous penicillin ther-
apy. Serum and CSF penicillin concentrations.
The concentrations of penicillin in the serum and
CSF clearly reflect the mode of drug administra-
tion (figure 1). With continuous iv infusion, a rel-
atively steady-state concentration of penicillin in
the serum was achieved 1 hr after therapy began.
The mean (± SD) levels of penicillin were 12.8 ±
1.8 jAg/ml at 2 hr, 13.9 ± 1.4 jAg/ml at 4 hr, 12.5 ±
2.0 jAg/ml at 6 hr, and 7.9 ± 1.7 jAg/ml at 8 hr; the
overall mean was 11.8 jAg/mI. Administration of
penicillin by intermittent (bolus) infusion pro-
duced mean peak levels of drug in serum of 9.9 ±
2.5 jAg/ml and 19.6 ± 4.1 jAg/ml at 1 and 5 hr, re-
spectively, and mean trough levels of 0.7 ± 0.2
jAg/ml and 1.8 ± 0.6 jAg/ml at 4 and 8 hr, respec-
tively.
The concentration of penicillin in CSF par-
alleled the concentration in serum (figure 1). A rel-
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Figure 1. Mean concentration of
penicillin in the serum and cerebro-
spinal fluid of rabbits with pneumo-
coccal meningitis during therapy with
equivalent doses of penicillin by con-
tinuous (0 - - - -0) or intermittent
(. .) iv infusion. Bars repre-
sent SE.
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ative steady-state concentration of penicillin was
seen in CSF of animals receiving continuous infu-
sions. The mean levels of penicillin were as fol-
lows: 0.6 ± 0.2IAg/ml at 2 hr, 0.4 ± 0.07 IAg/ml at 4
hr, 0.3 ± 0.07 IAg/ml at 6 hr, and 0.4 ± 0.08 IAg/ml
at 8 hr; the overall mean was 0.4 IAg/ml. The peak
CSF concentrations of penicillin achieved after
bolus infusion exceeded the highest levels obtained
with continuous infusion. At 1 and 5 hr of treat-
ment, the mean levels of penicillin in CSF were
0.96 ± 0.20 IAg/ml and 1.79 ± 0.67 IAg/ml, respec-
tively. Mean trough concentrations of penicillin in
the CSF were 0.12 ± O.OllAg/ml at 4 hr and 0.23 ±
0.07 IAg/ml at 8 hr. Eighteen of 28 individual sam-
ples of CSF from animals receiving bolus infu-
sions had trough levels of penicillin of <0.06
IAg/ml as compared with none of 29 samples
taken at the same time period from rabbits receiv-
ing the continuous infusion. Thus, higher peak
but lower trough levels of penicillin were seen in
the CSF of bolus-treated animals.
Bactericidal activit)'. in vivo. The mean change
in titer of bacteria in CSF of animals receiving
either continuous or intermittent infusions of
penicillin were examined at 1- and 2-hr intervals
(figure 2). Before the start of therapy, the mean
bacterial titers in CSF did not differ between ex-
perimental groups. Mean concentrations of 105.25
± 1.06 cfu/ml and 105.27 ± 1.21 cfu/ml were
found for the continuous and intermittent groups,
respectively (P> 0.1). With the initiation of ther-
apy, a rapid bactericidal effect was seen in each
group. This bactericidal effect was equivalent at
all time periods except for the interval between the
first and second hour of treatment. In the first
hour of treatment, the mean decline in bacterial
titers in CSF was 10°·20 ± 0.29 cfu/ml for the con-
tinuous group and 10°· 06 ± 0.17 for the intermit-
tent group (P> 0.1). However, between 1 and 2 hr
of treatment, the mean bacterial titer of the con-
tinuous group had decreased by only 10°·48 ± 0.31
cfu/ml, whereas the mean titer of the intermittent
or bolus group was reduced by 101.25 ± 0.26
cfu/ml (P < 0.05). After the second hour of treat-
ment, the magnitude of bacterial killing was the
same for both modes of drug administration. In
each group, mean titers of bacteria in CSF de-
creased by 1"\.11.5 logs during every 2-hr interval.
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Figure 2. Magnitude of bacterial
killing in the cerebrospinal fluid
of rabbits with pneumococcal menin-
gitis during therapy with equiva-
lent doses of penicillin by continuous
(0----0) or intermittent (. .)
iv infusion.
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Rate of bacterial killing. The rate of bacterial
killing in the CSF for the two experimental groups
was compared by least-squares regression analysis
(figure 3). Both experimental groups showed a
logarithmic first-order diminution in bacterial
titer. The slopes of the lines representing continu-
ous and intermittent modes of treatment were
- 0.613 and - 0.612, respectively, and thus nearly
were identical (P > 0.05).
The effect of the initial (before therapy) bac-
terial titer in the CSF on the rate of bacterial kill-
ing was examined (figure 4). The 30 infected ex-
perimental animals were divided arbitrarily into
two groups: those with initial titers of ~105 cfu/ml
and those with titers of <105 cfu/ml. The rates of
bacterial killing produced by the intermittent or
continuous mode of penicillin administration were
compared for each group by least-squares regres-
sion analysis. Sixteen animals had initial titers of
~ 105 cfu/ml. Eight received continuous and eight,
intermittent penicillin therapy. Fourteen animals
had bacterial titers in CSF of <105 cfu/ml, and
seven received either continuous or intermittent
infusion, respectively. Again, a logarithmic first-
order diminution in titer was seen in all four
groups, and the slopes (m) of these lines did not
differ statistically. Thus, the initial bacterial titer
did not influence the rate of bacterial killing in this
experimental model.
It is also evident that, whatever the mode of
drug administration, 8 hr of therapy was ade-
quate to sterilize the CSF of animals with initial
bacterial titers of <105 cfu/ml. At equivalent rates
of killing, animals with higher titers of bacteria in
the CSF would therefore require a longer duration
of treatment (extrapolated to a mean of 9-10 hr)
in order to achieve sterility. This fact was con-
firmed when the therapeutic outcome was ex-
amined.
Outcome of therapy. Administration of
penicillin for 8 hr by either the continuous or in-
termittent mode resulted in similar outcomes
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Figure 3. Rate of bacterial killing
in the cerebrospinal fluid of rabbits
with pneumococcal meningitis during
therapy with equivalent doses of pen-
icillin by continuous (0----0) or in-
termittent (. .) iv infusion.
Values were obtained by least-
squares regression analysis.
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(table 1). Ten of 15 rabbits receiving continuous
infusions of penicillin as well as 11 of 15 rabbits
treated with intermittent boluses of penicillin had
sterile CSF after 8 hr of treatment. Within these
groups all the animals with CSF bacterial titers of
<105 cfu/ml before treatment had a sterile CSF
after 8 hr. In contrast, of those animals with CSF
titers ~105 cfu/ml, only three of eight receiving
continuous therapy and four of eight receiving in-
termittent treatment had sterile CSF after 8 hr of
treatment. Thus, the initial bacterial titer, rather
than the mode of drug administration, determined
the outcome of therapy within the experimental
period.
Four partially treated animals (e.g, continuous
administration of penicillin for 4 hr; 105 units/hr)
were allowed to relapse and succumbed to infec-
tion within 24 hr. Thus, no spontaneous clearing
of meningitis occurred.
(2) Single-dose ampicillin therapy. Quantita-
tive "time-kill" experiments in vitro. Exposure of
S. pneumoniae to superinhibitory concentrations
of ampicillin (0.1, 1.0, or 10 IAg/ml) for 2 hr
resulted in a reproducible postantibiotic effect
(figure 5). This effect was reflected by the lag
phase after removal of ampicillin from the flasks
by centrifugation during which time no bacterial
multiplication was demonstrated. This interval,
defined as the time necessary to reach a bacterial
concentration 1 log/ml greater than that observed
at the end of centrifugation was 6.5, 6.7, and 7.6
hr for 0.1, 1.0, and 10 lAg of ampicillin/ml, respec-
tively. A maximal effect was apparent at ampicil-
lin concentrations that exceeded the MIC. In con-
trast, when the organism was exposed to 0.01 lAg
of ampicillin/ml for 2 hr, a concentration well
below the MIC of 0.08IAg/ml, bacterial concentra-
tions increased steadily and were indistinguishable
from those observed in control flasks without an-
tibiotic (figure 5). In the presence of 0.01 lAg of
ampicillin/ml, bacterial titers increased by 2-3
logs in the first 4-6 hr and then remained stable at
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Figure 4. Rate of bacterial killing
in CSF of rabbits with pneumococcal
meningitis during therapy with equiv-
alent doses of penicillin by con-
tinuous (0----0) or intermittent
( • .) iv infusion. Experimen-
tal animals were grouped by pretreat-
ment bacterial titers in CSF of >10'
cfu/ml (mean for continuous group,
106 .0 ' ± 0.97 cfu/ml; mean for in-
termittent group, 1Os.86 ± 1.12
cfu/ml) or of <lOS cfu/ml (mean for
continuous group, 104.37 ± 0.77;
mean for intermittent group, 104.56 ±
0.27 cfu/ml).
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Table 1. Results of penicillin treatment (8 hr) of ex-
perimental meningitis due to Streptococcus pneumoniae
in rabbits: comparison of intermittent vs. continuous
administration.
tion of bacteria in the CSF increased in all control
(untreated) animals; mean increases of 0.16 and
2.11 logs were observed after 8 and 24 hr, respec-
tively.
A postantibiotic effect, defined as a continued
cidal and static period after the concentration of
NOTE. CSF = cerebrospinal fluid.
108 and 109 cfu/ml for the duration of the ex-
periments.
Despite this prolonged postantibiotic effect, all
flasks demonstrated an increase in bacterial con-
centrations and were equivalent to controls by
10-12 hr after removal of the drug. In contrast,
when flasks containing S. pneumoniae were con-
tinuously incubated with stable superinhibitory
concentrations of ampicillin (0.1, 1.0, or 10
IAg/ml), all cultures were sterile by 18 hr.
In vivo. After induction of pneumococcal
meningitis in rabbits by procedures identical with
those utilized for the penicillin experiments, a
series of animals were treated with a single iv bolus
of ampicillin at dosages that varied over a wide
range (3.25-62.5 mg/kg). These dosages were
chosen to achieve measurable peak concentrations
of ampicillin in CSF that were below, approxi-
mately equal to, and well above the MIC for the
test strain ("-'0.1 IAg/ml). Bacterial titers declined
in all treated rabbits. In contrast, the concentra-
Rabbits
No. with sterile CSF after
treatment/total no.
No. with sterile CSF after
treatment and
Initial bacterial titer
<10' cfu/ml
Initial bacterial titer
~1O' cfu/ml
Continuous
10/15
7/7
3/8
Intermittent
11/15
7/7
4/8
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Figure 5. Concentration (loglo cful
ml) of Streptococcus pneumoniae vs.
time before, during, and after ex-
posure to ampicillin in vitro. Ex-
posure interval (1-3 hr) is indicated
by the cross-hatched bar (upper left).
Concentrations of ampicillin (j..tg/ml)
are as follows: (0------0) = control
(no ampicillin); (e e) = 0.01;
(e ----e) = 0.1; (.&----.&) = 1.0;
and(~) = 10.
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ampicillin in CSF had fallen below 0.1 Jig/ml, was
observed in all animals (figure 6). A shorter modi-
fied effect (total time, 6-8 hr after infusion) also
was observed in two animals in which all measured
ampicillin concentrations were ~0.1 Jig/ml (figure
6). Thus even subinhibitory concentrations of am-
picillin produced a clear cidal-static effect in vivo.
The duration of this postantibiotic effect was
variable. An initial rapid decline in bacterial titer
was observed in all animals; the decline was fol-
lowed by a static phase prior to the resumption of
bacterial multiplication (figure 6). For purposes of
comparison, the postantibiotic effect was defined
as the interval from the time when concentrations
of ampicillin in CSF first dropped below 0.1
Jig/ml (the MIC of the test strain) until bacterial
titers in CSF were loglo 1.0 cfu/ml higher than the
bacterial concentration achieved at the nadir of
the curve. The duration of the initial decline in
bacterial titer was variable (1-6 hr) and did not
correlate with peak concentrations of ampicillin in
CSF. The second, static phase also varied so that
the total duration of the postantibiotic effect was
6-12 hr. Two of three animals that received the
highest dose of ampicillin (62.5 mg/kg) had sterile
CSF after 4-6 hr and were presumed "cured".
Discussion
This study examined two areas of potential impor-
tance in the therapy of bacterial meningitis: (1) the
influence of mode of drug administration (con-
tinuous vs. intermittent bolus) on antibiotic phar-
macokinetics within the CSF, bactericidal activity,
kinetics of bacterial killing in vivo, and therapeu-
tic outcome in experimental pneumococcal men-
ingitis; and (2) the influence of a short duration of
exposure to ampicillin of bacteria in the CSF on
the development of a postantibiotic effect in vivo.
When equivalent therapeutic doses of penicillin
S. pneu- 5
moniae
Log10
cfu/ml
3
2
Figure 6. Counts of bacteria (ordinate) in two repre-
sentative animals with experimental pneumococcal men-
ingitis treated with a single dose of ampicillin plotted vs.
time after injection (abscissa). The area under the curve
for concentration of ampicillin in cerebrospinal fluid
varied; (0-----0) = < 0.1 j..tg/ml·hr; (e--e)= 0.7
j..tg/ml·hr.
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were employed, the results in this experimental
model were essentially identical for both continu-
ous and intermittent therapy. A postantibiotic ef-
fect in vivo was demonstrated when the single
bolus of ampicillin was given; this effect also was
present after exposure to near or subinhibitory
concentrations of ampicillin.
The choice of the most effective mode of anti-
biotic administration in serious infections has
been a subject of continuous debate. In studies
of mice with streptococcal peritoneal infections,
where survival was used as a measure of treatment
outcome, the avoidance of long periods of subin-
hibitory concentrations of penicillin in the serum
appeared critical [8]. Although the actual mode of
drug administration was irrelevant in this study,
the findings tended to support advocates of con-
tinuous drug administration.
Arguments also have been made in favor of in-
termittent iv injections of antibiotic, especially in
the treatment of bacterial endocarditis [19]. The
resultant higher levels of drug achieved in blood
with this mode of administration theoretically
would allow increased diffusion of the antimicro-
bial agent into an infected vegetation. Recently,
Barza et al. observed an increased accumulation
of ampicillin within sc fibrin clots in rabbits after
intermittent as compared to continuous administra-
tion [4]. In addition, it has been postulated that
brief periods of low concentrations of antibiotic
might permit bacterial multiplication and, there-
by, enhance the susceptibility of the remaining
bacteria to antimicrobial action [20, 21].
This controversy has particular relevance in the
treatment of meningitis. The blood-brain barrier
limits the entry of most antimicrobial agents into
the CSF [22]. Even in the presence of inflamed
meninges, when a generalized nonspecific increase
in membrane permeability allows enhanced drug
penetration [23], the therapeutic margin may be
small.
Penetration of penicillin into the CSF and other
foci of infection has been studied since the intro-
duction of this antimicrobial agent into clinical
use [24]. The chemical characteristics of penicillin
are major factors limiting its entry into the CSF
[25]. Protein binding, acidity, ionization, and lack
of a transport system result in slow diffusion
across the leptomeninges. Concentration of pen-
icillin in the CSF is further limited by the exis-
tence of an active transport process that pumps
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penicillin out of the CSF and into the serum [26].
Thus the cornerstone of treatment of infections in
the CSF has been the parenteral administration of
large doses of antibiotic to achieve maximal serum
concentrations that enhance diffusion into the in-
fected site [27].
Debate has centered, however, on which mode
of administration (continuous infusion or inter-
mittent bolus injection) is most effective in pro-
ducing high concentrations of antibiotic in CSF
and a rapid bactericidal effect in vivo. Plorde et
al. [5] examined the kinetics of penicillin pene-
tration through uninflamed and inflamed men-
inges (aseptic meningitis) of dogs with use of dif-
ferent modes of iv injection of antibiotic. Early in
therapy, high levels of penicillin were detected in
the CSF only after bolus infusion; however, after
several hours of therapy, the levels achieved with
continuous infusions were as high as, or even
slightly higher than, those produced by bolus infu-
sion. These studies did not include the effect of
these differences on the elimination of bacteria
from the CSF.
We examined the kinetics of bacterial killing in
the CSF in experimental pneumococcal meningitis
as a function of the mode of administration of
equivalent doses of penicillin. The therapeutic reg-
imens chosen represent those in common clinical
usage and achieved serum levels equivalent to
those achieved in humans. As in Plorde's studies
[5], higher concentrations of penicillin in CSF were
detected earlier after intermittent bolus administra-
tion than after continuous iv infusion. Despite
these differences in concentration, only slight dif-
ferences in bacterial killing were seen. An en-
hanced bactericidal effect was seen with intermit-
tent infusion of penicillin early in the treatment
period (only between the first and second hours of
therapy). This effect probably reflected the higher
initial levels of penicillin found in the CSF after
bolus administration and thus the earlier initiation
of bacterial killing. Over the remaining 6 hr of
treatment, the magnitude of bacterial killing
(change in log titer) was equivalent for groups of
animals receiving both intermittent and continu-
ous dosages.
Despite the low (sub-MIC in 18 of 28 animals)
trough levels of penicillin in CSF of animals re-
ceiving penicillin by bolus every 4 hr, no rebound
in bacterial titers was noted during the 1-2 hr when
levels of drug were low. This finding is consistent
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with the persistent suppression (~2 hr) of bacte-
rial growth noted in vitro after short periods of ex-
posure of test cultures to penicillin (postantibiotic
effect) [11].
The rate of bacterial killing did not differ with
the modes of therapy. Both continuous and inter-
mittent administration of penicillin resulted in a
straight-line logarithmic decrease in bacterial
counts, and the decrease was independent of the
titer of bacteria in the CSF before treatment.
Thus, neither the quantity of bacteria in the initial
sample of CSF nor the manner of penicillin ad-
ministration influenced the rate at which bacteria
were killed.
In contrast, the duration of therapy required to
sterilize the CSF correlated directly with the initial
bacterial titer of the CSF. An 8-hr period of treat-
ment reduced the bacterial count by a mean of 5
logs and therefore was adequate to sterilize the
CSF of rabbits with initial bacterial titers of <105
cfu/ml. At an equivalent rate of bacterial killing,
500/0 of animals with higher initial titers (>105
cfu/ml) still had detectable bacterial counts in the
CSF at the end of the experiment. A similar obser-
vation on the role of initial bacterial titers was
made by Feldman [28], who studied humans with
meningitis. A higher rate of complications and a
slower response to therapy was seen in patients
with meningitis whose bacterial titers before treat-
ment exceeded 107 cfu/ml as compared with the
response of patients who had lower CSF titers.
These initial experiments resulted in levels of
penicillin in CSF that were at or above the MIC
for the test strain for virtually the entire 8 hr of
observation. Thus, they are equivalent to in vitro
"time-kill curves" with continuous exposure to
stable levels of antibiotic. Under these conditions,
titers 'Of S. pneumoniae continually decline until
sterility is achieved during exposure to 0.1, 1.0, or
IOllg of ampicillin/ml. In this situation, and in the
experiments with penicillin in this study, a postan-
tibiotic effect cannot be discerned. If, however,
the bacteria are exposed to ampicillin for a rela-
tively short period of time, a postantibiotic effect
is observed in vitro. In this study, when similar
conditions were designed for exposure to ampicil-
lin in the CSF in rabbits with experimental pneu-
mococcal meningitis, a postantibiotic effect was
demonstrated in vivo.. This phenomenon was ob-
served in all animals.
The effect of ampicillin in experimental men-
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ingitis was greater than that seen in vitro. The per-
sistent effect of antibiotics on bacteria has been
demonstrated in vitro for a number of different
species: S. aureus [11-13], S. pneumoniae, Strepto-
coccus [29], and E. coli [12]. The results are quali-
tatively similar for each of these organisms. A
postantibiotic effect was observed with several an-
tibiotics including penicillins, cephalosporins,
macrolides, chloramphenicol, and vancomycin
[11, 12]. However, the duration of the effect
varies (generally 1.5 to 5 hr after a 2-hr exposure)
and is not demonstrable for some agents (e.g.,
gentamicin). A maximal postantibiotic effect
could be achieved by an increase in the duration of
exposure to the drug, and the effect was prolonged
slightly if the test concentration of drug was in-
creased from one to 10 times the MIC. Similar re-
sults were found in this study. A near maximal
postantibiotic effect was seen when log-phase S.
pneumoniae was exposed to ampicillin at the MIC
(0.1 Ilg/ml) for the test strain (figure 5). Further
increases in concentration of drug (e.g., 1 or 10
~g/ml) did not appreciably augment the duration
of the postantibiotic effect.
This study demonstrates that a postantibiotic
effect also occurs in vivo (figure 6). This pheno-
menon could reflect either nonlethal damage done
by the drug or continued persistence at the bac-
terial binding site. Qualitatively, the postantibiotic
effect in the CSF was similar to that observed in
the parallel in vitro experiments but differed in
two important respects: (1) it occurred after ex-
posure to near- or subinhibitory concentrations of
ampicillin; and (2) the maximal effect lasted con-
siderably longer.
The in vivo model is obviously more complex
than the in vitro situation. Variables such as
growth rate of bacteria in the CSF, pharmaco-
kinetics of entry and persistence of drug in the
CSF, and various host factors must be considered.
In our model the bacterial titer in untreated ani-
mals remains essentially unchanged during the
first 8 hr of observation. In addition, if the organ-
isms are removed and placed in either fresh broth
or sterile CSF, there is a long latent period before
titers begin to increase [30]. Therefore, the rate of
growth of the bacteria in the CSF in the early
stages of disease in this model appears to be slow.
However, this phenomenon would be expected to
decrease rather than increase the duration of a
postantibiotic effect, since the antibacterial activ-
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ity of all f3-lactam antibiotics is greatest in rapidly
growing cells.
In this study exposure of S. pneumoniae in vivo
to near- or subinhibitory concentrations of ampi-
cillin in the CSF «0.1 IAg/ml) for short periods
«1-3 hr) still resulted in an antibacterial effect of
6-7 hr. Some effects of subinhibitory concentra-
tions of antibiotics on bacterial morphology in
vitro are well known [13]. In our model, scanning
electron microscopy of specimens of CSF aspir-
ated 3 hr after exposure to ampicillin revealed
large and aberrant pneumococcal forms. Potential-
ly even more important was the effect of sub-MIC
concentrations of antibiotic on the host defense
mechanism. When E. coli is exposed to chloram-
phenicol in vitro, an enhancement in bactericidal
activity of leukocytes is seen. This postantibiotic
effect was dependent on active factors in serum
(e.g., antibody and complement) and did not oc-
cur at sub-MIC concentrations of chlorampheni-
col; however, very short exposure times (10 min)
were used [12]. These effects may be due to pertur-
bation of the outer membrane and a change to
serum sensitivity [31]. Antibiotics also may alter
lysozyme function [32], antibody and complement
[15], or phagocytic ability [11, 33, 34]. In addi-
tion, pretreatment of staphylococci or streptococ-
ci with sub-MICs of penicillin facilitates phagocyt-
ic ingestion and killing [35, 36]. These effects may
explain, in part, why the postantibiotic effect was
observed in vivo in our experiments at near to sub-
MIC levels of ampicillin in the CSF when similar
results have not been apparent in other in vitro ex-
periments [11, 12]. The fact that the postantibiotic
effect is of longer duration in vivo and is achieved
with relatively short, low-level exposure to ampi-
cillin may reflect the contribution of host defense
mechanisms.
The results outlined in these studies may have
important clinical relevance. The highest immedi-
ate concentrations of penicillin in the CSF were
achieved after the injection of a bolus, and this
correlated with a significant, but small, enhance-
ment in early bactericidal effect. Thus, in a criti-
cally ill adult patient (with normal renal function)
with pneumonococcal meningitis, a therapeutic
advantage might be gained by the initial admini-
stration of penicillin by iv bolus (1-2 x 106 units)
followed by either mode of drug delivery for a
total of 2.0 x 107 units daily. The clinical rele-
vance of the postantibiotic effect observed in vivo
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is not known at this time. However, even sub-MIC
levels of drug in the CSF produced this pheno-
menon, a fact that may be of importance in the
results of diagnostic procedures in partially
treated outpatients receiving orally administered
drugs and in the therapeutic results obtained when
antibiotics are administered intermittently in full
doses. The results of a study of single, large-dose
penicillin therapy of meningococcal meningitis in
Africa tend to support this concept [37].
References
1. Eagle, H., Fleischman, R., Musselman, A. D. The effec-
tive concentrations of penicillin in vitro and in vivo for
streptococci, pneumococci, and Treponema pallidum.
J. Bacteriol. 59:625-643, 1950.
2. Eagle, H., Fleischman, R., Musselman, A. D. Effect of
schedule of administration on the therapeutic efficacy of
penicillin: importance of the aggregate time penicillin re-
mains at effectively bactericidal levels. Am. J. Med.
9:280-299, 1950.
3. Schmidt, L. H., Walley, A. The influence of the dosage
regimen on the therapeutic effectiveness of penicillin G
in experimental lobar pneumonia. J. Pharmacol. Exp.
Ther. 103:479-488, 1951.
4. Barza, M., Brusch, J., Bergeron, M. G. Weinstein, L.
Penetration of antibiotics into firbrin loci in vivo. III.
Intermittent vs. continuous infusion and the effects of
probenecid. J. Infect. Dis. 129:73-78, 1974.
5. Plorde, J. J., Garcia, M., Petersdorf, R. G. Studies on the
pathogenesis of meningitis. IV. Penicillin levels in the
cerebrospinal fluid in experimental meningitis. J. Lab.
Clin. Med. 64:960-969, 1964.
6. Meads, M., Harris, H. W., Finland, M. Treatment of
pneumococcal pneumonia with penicillin. N. Engl. J.
Med. 232:747-755, 1945.
7. Weinstein, L., Daikos, G. The treatment of scarlet fever
with crystalline penicillin G administered orally or
parenterally twice a day. Am. Pract. Digest Treatment
2:60-64, 1951.
8. Eagle, H., Fleischman, R., Levy, M. "Continuous" vs.
"discontinuous" therapy with penicillin. N. Engl. J.
Med. 248:481-488, 1953.
9. Parker, R. F., Marsh, H. C. Action of penicillin on
Staphylococcus. J. Bacteriol. 51: 181-186, 1946.
10. Parker, R. F., Luse, S. The action of penicillin on
Staphylococcus: further observations on the effect of a
short exposure. J. Bacteriol. 56:75-81, 1948.
11. McDonald, P. J., Craig, W. A., Kunin, C. M. Persistent
effect of antibiotics on Staphylococcus aureus after ex-
posure for limited periods of time. J. Infect. Dis.
135:217-223, 1977.
12. Pruul, H., McDonald, P. J. Enhancement of leukocyte ac-
tivity against Escherichia coli after brief exposure to
chloramphenicol. Antimicrob. Agents. Chemother.
16:695-700, 1979.
13. Lorian, V. Some effects of subinhibitory concentrations of
Pulse Dosing in Experimental Meningitis
antibiotics on bacteria. Bull. N.Y. Acad. Med. 51:
1046-1055, 1975.
14. Friedman, H., Warren, G. H. Enhanced susceptibility of
penicillin-resistant staphylococci to phagocytosis after
in vitro incubation with low doses of nafcillin. Proc.
Soc. Exp. BioI. Med. 146:707-711, 1974.
15. Friedman, H., Warren, G. H. Antibody-mediated bacteri-
olysis: enhanced killing of cyclacillin-treated bacteria.
Proc. Soc. Exp. BioI. Med. 153:301-304, 1976.
16. Sherertz, R. J., Dacey, R., Sande, M. A. Cefamandole in
the therapy of experimental pneumococcal meningitis.
J. Antimicrob. Chemother. 2:159-165, 1976.
17. Sande, M. A., Sherertz, R. J., Zak, 0., Strausbaugh, L. J.
Cephalosporin antibiotics in therapy of experimental
Streptococcus pneumoniae and Haemophilus influenzae
meningitis in rabbits. J. Infect. Dis. (Suppl.)
137:S161-S168, 1978.
18. Bennett, J. V., Brodie, J. L., Benner, E. J., Kirby,
W. M. M. Simplified accurate method for antibiotic
assay of clinical specimens. Applied Microbiology
14:170-177,1966.
19. Gerber, I. E., Shwartzman, G., Baehr, G. Penetration of
penicillin into foci of infection. J.A.M.A. 130:761-764,
1946.
20. Bigger, J. W. Treatment of staphylococcal infections with
penicillin by intermittent sterilization. Lancet 2:497-
500, 1944.
21. McDermott, W. Microbial persistence. Yale J. BioI. Med.
30:257-291, 1958.
22. Barlow, C. R. Clinical aspects of the blood-brain barrier.
Annu. Rev. Med. 15:187-202, 1964.
23. Ruedy, J. The concentrations of penicillins in the
cerebrospinal fluid and brain of rabbits with experimen-
tal meningitis. Can. J. Physiol. Pharmacol. 43 :763-772,
1965.
24. Dumoff-Stanley, E., Dowling, H. F., Sweet, L. K. The ab-
sorption into and distribution of penicillin in
cerebrospina,1 fluid. J. Clin. Invest. 25:87-93, 1946.
25. Schanker, L. S. Passage of drugs across body membranes.
Pharmacol. Rev. 14:501-530, 1962.
26. Fishman, R. A. Blood brain and CSF barriers to peni-
cillin and related organic acids. Arch. Neurol.
15:113-124, 1966.
109
27. Dowling, H. F., Sweet, L. K. Robinson, J. A., Zellers, W.
W., Hirsh, H. L. The treatment of pneumococcal men-
ingitis with massive doses of systemic penicillin. Am. J.
Med. Sci. 217:149-156, 1949.
28. Feldman, W. E. Relation of concentrations of bacteria and
bacterial antigen in cerebrospinal fluid to prognosis in
patients with bacterial meningitis. N. Eng!. J. Med.
296:433-435, 1977.
29. Eagle, H., Musselman, A. D. The slow recovery of
bacteria from the toxic effects of penicillin. J. Bacteriol.
58:475-490, 1949.
30. Strausbaugh, L. J., Sande, M. A. Factors influencing the
therapy of experimental Proteus mirabilis meningitis in
rabbits. J. Infect. Dis. 137:251-260, 1978.
31. Reynolds, B. L., Pruul, H. Sensitization of complement-
resistant smooth gram-negative bacterial srains. Infect.
Immun. 3:365-372, 1971.
32. Warren, G. H., Gray, J. Effect of sublethal concentrations
of penicillins on the lysis of bacteria by lysozyme and
trypsin. Proc. Soc. Exp. BioI. Med. 120:504-511, 1965.
33. Adam, D., Schaffert, W., Marget, W. Enhanced in vitro
phagocytosis of Listeria monocytogenes by human
monocytes in the presence of ampicillin, tetracycline and
chloramphenicol. Infect. Immun. 9:811-814, 1974.
34. Nishida, M., Mine, Y., Nonoyama, 5., Yokota, Y. Effect
of antibiotics on the phagocytosis and killing of
Pseudomonas aeruginosa by rabbit polymorphonuclear
leukocytes. Chemotherapy 22:203-210, 1976.
35. Yourtee, E., Metcalf, J. A., Root, R. K. Augmented kill-
ing of penicillin pretreated S. aureus by human neutro-
phils: role of complement [abstract]. Clin. Res. 28:
383A, 1980.
36. Isturiz, R., Metcalf, J. A., Root, R. K. Augmented killing
of streptococci by human neutrophils after penicillin
pretreatment [abstract]. Clin. Res. 28:512A, 1980.
37. MacFarlane, J. T., Anjorin, F. I., Cleland, P. G., Hassan-
King, M., Tor-Agbidye, 5., Wali, S. S., Weir, W. R. C.,
Whittle, H. c., Yahaya, H. N., Greenwood, B. M.
Single injection treatment of meningococcal meningitis.
1. Long-acting penicillin. Trans. R. Soc. Trop. Med.
Hyg. 73:693-697, 1979.
